# Ciclosporin

## SANDIMMUN Neoral 100mg

| TAH Drug Code      | [OSAN1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSAN1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of transplant rejection after organ and bone marrow transplants; prevention of graft-versus-host disease; active non-infectious uveitis of the central or posterior segments of the eye with a risk of blindness, unresponsive to conventional therapy; recurrent inflammation in Behcet's disease with retinal involvement; severe psoriasis unresponsive or unsuitable for alternative therapies; severe rheumatoid arthritis unresponsive or unsuitable for standard therapy; primary nephrotic syndrome with steroid resistance or steroid dependence (mainly characterized by minimal change disease or focal segmental glomerulosclerosis upon biopsy), unresponsive to cytostatic treatment, and with renal function index above 50% of normal; atopic dermatitis. |
| Dosing             | Transplant rejection initial 10-15 mg/kg before transplant, then divided twice daily into 2 equal doses for 1 to 2 weeks, titrate subsequent doses to achieve predefined blood concentrations. Plaque psoriasis initial 2.5 mg/kg/day in divided doses twice daily. Maximum 5 mg/kg/day. Rheumatoid arthritis initial 3 mg/kg/day in divided doses twice daily. Maximum 5 mg/kg/day. Atopic dermatitis 2.5-5 mg/kg/day in divided doses twice daily. Nephrotic syndrome adult 5 mg/kg/day, children 6 mg/kg/day.                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Hypersensitivity; malignant neoplasms; uncontrolled hypertension; psoriasis; lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Hypertension; hepatoxicity; tremor; paraesthesia, hypertrichosis, facial oedema, acne; gingival hypertrophy; hyperkalaemia, fluid retention; increased susceptibility to infections; GI symptoms. Potentially Fatal: Nephrotoxicity; convulsions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/cyclosporine-ciclosporin-systemic-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

## Sandimmun Neoral 25mg (兒童)

##### 臨採

| TAH Drug Code      | [OSAN25](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSAN25)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of transplant rejection after organ and bone marrow transplants; prevention of graft-versus-host disease; active non-infectious uveitis involving the central or posterior segments of the eye with a risk of blindness, unresponsive to conventional therapy; recurrent inflammation in Behcet's disease with retinal involvement; severe psoriasis unresponsive or unsuitable for alternative therapies; severe rheumatoid arthritis unresponsive or unsuitable for standard therapy; primary nephrotic syndrome with steroid resistance or steroid dependency (mainly characterized by minimal change disease or focal segmental glomerulosclerosis upon biopsy), unresponsive to cytostatic treatment, with renal function index above 50% of normal; acquired severe aplastic anemia; atopic dermatitis. |
| Dosing             | Transplant rejection initial 10-15 mg/kg before transplant, then divided twice daily into 2 equal doses for 1 to 2 weeks, titrate subsequent doses to achieve predefined blood concentrations. Plaque psoriasis initial 2.5 mg/kg/day in divided doses twice daily. Maximum 5 mg/kg/day. Rheumatoid arthritis initial 3 mg/kg/day in divided doses twice daily. Maximum 5 mg/kg/day. Atopic dermatitis 2.5-5 mg/kg/day in divided doses twice daily. Nephrotic syndrome adult 5 mg/kg/day, children 6 mg/kg/day.                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Hypersensitivity to cycloSPORINE or any of ingredient in the formulation of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Common: Hypertension (13-53%), Hirsutism (21-45%), Drug-induced gingival hyperplasia (4-16%), Headache (1-15%), Tremor (12-55%), Application site reaction (8%), Blepharitis (Ophthalmic route 1-5%), Burning sensation in eye (Ophthalmic route, 17%), Conjunctival hyperemia (Ophthalmic route, 1-6%), Eye irritation (Ophthalmic route, 1-5%), Pain in eye (Ophthalmic route, emulsion 1-12% ; solution, 22%). Serious: Hyperkalemia, Hypomagnesemia, Hepatotoxicity (7% or less), Disease caused by Polyomavirus, Encephalopathy, Progressive multifocal leukoencephalopathy, Seizure (1-5%), Hemolytic uremic syndrome, Nephrotoxicity (25-38%), Infectious disease.                                                                                                                                                |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/cyclosporine-ciclosporin-systemic-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

